Newsletter

Join Our Mailing List, Never miss the news


Newsletters
  • All
  • TrialX
  • CureTalks
29 June, 2018
Latest Advances in Myeloma Treatment: ASCO and EHA 2018 Highlights
14 June, 2018
Get patients to e-Consent with TrialX’s mobile healthcare technology
31 May, 2018
Reversing Blindness with New FDA Approved Retinal Gene Therapy
22 March, 2018
Endometriosis - The How & Why and Recent Advances in Treatment with Dr Camran Nezhat
16 March, 2018
Think. Design. Launch. Create mobile research study apps without code
20 February, 2018
Becoming a Part of the Solution: The Metastatic Prostate Cancer Project
24 January, 2018
Highlights from the International Lyme and Associated Diseases, 18th Annual Scientific Conference
14 December, 2017
Think. Design. Launch. Create mobile research study apps without code.
30 November, 2017
Understanding the Medical and Legal Aspects of Surrogacy - An Option in Infertility
02 November, 2017
Get your clinical research data in real-time in the palm of your hand
20 October, 2017
Dr. Carl June’s CAR-T Cell Journey and the Cancer Treatment Revolution
26 September, 2017
Climbing Mount Kilimanjaro for the MMRF with Myeloma Patient Advocate Matt Goldman
30 August, 2017
Multiple Myeloma: Minimal Residual Disease Testing as an End Point Treatment
24 July, 2017
Modern Imaging Techniques in the Diagnosis and Management of Prostate Cancer
28 June, 2017
The MMRF Precision Medicine Model - How Far From Myeloma Cure Are We?
28 May, 2017
High Risk Pregnancies - Causes and Care with Dr. Shannon Clark
28 April, 2017
Living Well with Prostate Cancer with Dr. Paul Schellhammer
19 April, 2017
iConnect advanced features allows making your own clinical trial flyers and generate trial reports directly from your dashboard.
30 March, 2017
Nonsecretory Multiple Myeloma: Options in Assessment and Treatment with Dr. Frits Van Rhee
06 March, 2017
With new features added, iConnect allows investigators to improve online awareness of their trials and monitor recruitment metrics.
30 January, 2017
Myeloma 2016 Year in Review and Outlook for 2017 with Dr. Ravi Vij  
traffic stats